Last reviewed · How we verify
ETH-155008
At a glance
| Generic name | ETH-155008 |
|---|---|
| Also known as | study drug, Study drug |
| Sponsor | Shengke Pharmaceuticals Pty Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ETH-155008 CI brief — competitive landscape report
- ETH-155008 updates RSS · CI watch RSS
- Shengke Pharmaceuticals Pty Ltd portfolio CI